Detalhe da pesquisa
1.
Metabolomic changes in vertebrate host during malaria disease progression.
Cytokine
; 112: 32-43, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30057363
2.
Vivax infection alters peripheral B-cell profile and induces persistent serum IgM.
Parasite Immunol
; 40(10): e12580, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30102786
3.
Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats.
Int J Toxicol
; 35(4): 420-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27278417
4.
Multifaceted Role of Heme during Severe Plasmodium falciparum Infections in India.
Infect Immun
; 83(10): 3793-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26169278
5.
Evidence of IL-17, IP-10, and IL-10 involvement in multiple-organ dysfunction and IL-17 pathway in acute renal failure associated to Plasmodium falciparum malaria.
J Transl Med
; 13: 369, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26602091
6.
Single episode of mild murine malaria induces neuroinflammation, alters microglial profile, impairs adult neurogenesis, and causes deficits in social and anxiety-like behavior.
Brain Behav Immun
; 42: 123-37, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24953429
7.
Intravenous ß-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
J Antimicrob Chemother
; 67(11): 2713-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22899802
8.
Plasmodium riboprotein PfP0 induces a deviant humoral immune response in Balb/c mice.
J Biomed Biotechnol
; 2012: 695843, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315513
9.
Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study.
Malar J
; 10: 384, 2011 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22196439
10.
Self-microemulsifiyng suppository formulation of ß-artemether.
AAPS PharmSciTech
; 11(3): 1179-84, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20661674
11.
A history of juvenile mild malaria exacerbates chronic stress-evoked anxiety-like behavior, neuroinflammation, and decline of adult hippocampal neurogenesis in mice.
J Neuroimmunol
; 348: 577363, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919145
12.
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Int J Pharm
; 364(1): 119-26, 2008 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765274
13.
Malaria vaccine: a current perspective.
J Vector Borne Dis
; 45(1): 1-20, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18399312
14.
Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model.
Eur J Pharm Biopharm
; 123: 95-107, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122736
15.
Atovaquone oral bioavailability enhancement using electrospraying technology.
Eur J Pharm Sci
; 111: 195-204, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28974387
16.
Corrigendum to article "Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies" [Int. J. Pharm. 431(1-2) (2012) 149-160].
Int J Pharm
; 616: 121616, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232621
17.
Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency.
Int J Pharm
; 511(1): 473-487, 2016 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27421912
18.
Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria.
Int J Pharm
; 513(1-2): 504-517, 2016 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27596113
19.
Bioavailability enhancement of atovaquone using hot melt extrusion technology.
Eur J Pharm Sci
; 86: 103-14, 2016 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26969110
20.
Heterozygous mutants of TIRAP (S180L) polymorphism protect adult patients with Plasmodium falciparum infection against severe disease and mortality.
Infect Genet Evol
; 43: 146-50, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27166096